CAH
Income statement / Annual
Last year (2025), Cardinal Health, Inc.'s total revenue was $222.58 B,
a decrease of 1.87% from the previous year.
In 2025, Cardinal Health, Inc.'s net income was $1.56 B.
See Cardinal Health, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
06/30/2025 |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
| Operating Revenue |
$222.58 B |
$226.83 B |
$204.98 B |
$181.33 B |
$162.47 B |
$152.92 B |
$145.53 B |
$136.81 B |
$129.98 B |
$121.55 B |
| Cost of Revenue |
$214.41 B
|
$219.41 B
|
$198.11 B
|
$174.84 B
|
$155.69 B
|
$146.05 B
|
$138.70 B
|
$129.63 B
|
$123.43 B
|
$115.00 B
|
| Gross Profit |
$8.17 B
|
$7.41 B
|
$6.89 B
|
$6.48 B
|
$6.78 B
|
$6.87 B
|
$6.83 B
|
$7.18 B
|
$6.54 B
|
$6.54 B
|
| Gross Profit Ratio |
0.04
|
0.03
|
0.03
|
0.04
|
0.04
|
0.04
|
0.05
|
0.05
|
0.05
|
0.05
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$4.60 B
|
$3.78 B
|
$3.65 B
|
| Selling & Marketing Expenses |
$5.38 B
|
$5.00 B
|
$0.00
|
$0.00
|
$4.53 B
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$5.38 B
|
$5.00 B
|
$4.80 B
|
$4.51 B
|
$4.53 B
|
$4.57 B
|
$4.48 B
|
$4.60 B
|
$3.78 B
|
$3.65 B
|
| Other Expenses |
$511.00 M
|
$1.17 B
|
$1.32 B
|
$2.58 B
|
$1.77 B
|
$6.39 B
|
$294.00 M
|
$2.46 B
|
$649.00 M
|
$436.00 M
|
| Operating Expenses |
$5.89 B
|
$6.17 B
|
$6.12 B
|
$7.09 B
|
$6.31 B
|
$10.97 B
|
$4.77 B
|
$7.06 B
|
$4.42 B
|
$4.08 B
|
| Cost And Expenses |
$220.30 B
|
$225.58 B
|
$204.23 B
|
$181.93 B
|
$162.00 B
|
$157.02 B
|
$143.47 B
|
$136.68 B
|
$127.86 B
|
$119.09 B
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$215.00 M
|
$51.00 M
|
$84.00 M
|
$147.00 M
|
$180.00 M
|
$238.00 M
|
$294.00 M
|
$329.00 M
|
$201.00 M
|
$178.00 M
|
| Depreciation & Amortization |
$790.00 M
|
$710.00 M
|
$692.00 M
|
$692.00 M
|
$783.00 M
|
$913.00 M
|
$1.00 B
|
$1.03 B
|
$717.00 M
|
$641.00 M
|
| EBITDA |
$3.11 B |
$1.96 B |
$1.44 B |
$55.00 M |
$1.29 B |
-$2.62 B |
$3.05 B |
$1.13 B |
$2.84 B |
$3.10 B |
| EBITDA Ratio |
0.01
|
0.01
|
0.01
|
0
|
0.01
|
-0.02
|
0.02
|
0.01
|
0.02
|
0.03
|
| Operating Income Ratio |
0.01
|
0.01
|
0
|
-0
|
0
|
-0.03
|
0.01
|
0
|
0.02
|
0.02
|
| Total Other Income/Expenses Net |
-$174.00 M
|
-$42.00 M
|
-$89.00 M
|
-$177.00 M
|
-$149.00 M
|
$326.00 M
|
-$309.00 M
|
-$354.00 M
|
-$196.00 M
|
-$183.00 M
|
| Income Before Tax |
$2.10 B
|
$1.20 B
|
$663.00 M
|
-$784.00 M
|
$323.00 M
|
-$3.77 B
|
$1.75 B
|
-$228.00 M
|
$1.92 B
|
$2.28 B
|
| Income Before Tax Ratio |
0.01
|
0.01
|
0
|
-0
|
0
|
-0.02
|
0.01
|
-0
|
0.01
|
0.02
|
| Income Tax Expense |
$532.00 M
|
$348.00 M
|
$332.00 M
|
$153.00 M
|
-$289.00 M
|
-$79.00 M
|
$386.00 M
|
-$487.00 M
|
$630.00 M
|
$845.00 M
|
| Net Income |
$1.56 B
|
$852.00 M
|
$330.00 M
|
-$938.00 M
|
$611.00 M
|
-$3.69 B
|
$1.36 B
|
$256.00 M
|
$1.29 B
|
$1.43 B
|
| Net Income Ratio |
0.01
|
0
|
0
|
-0.01
|
0
|
-0.02
|
0.01
|
0
|
0.01
|
0.01
|
| EPS |
6.48 |
3.48 |
1.26 |
-3.34 |
2.09 |
-12.6 |
4.54 |
0.82 |
4.06 |
4.36 |
| EPS Diluted |
6.45 |
3.45 |
1.26 |
-3.34 |
2.08 |
-12.6 |
4.53 |
0.81 |
4.03 |
4.32 |
| Weighted Average Shares Out |
$241.00 M
|
$245.00 M
|
$261.00 M
|
$279.00 M
|
$292.00 M
|
$293.00 M
|
$300.00 M
|
$313.00 M
|
$317.00 M
|
$327.00 M
|
| Weighted Average Shares Out Diluted |
$242.00 M
|
$247.00 M
|
$262.00 M
|
$279.00 M
|
$294.00 M
|
$293.00 M
|
$301.00 M
|
$315.00 M
|
$320.00 M
|
$330.00 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
